Portola Pharmaceuticals, Inc. Embedded Derivative, Loss on Embedded Derivative
Portola Pharmaceuticals, Inc. reported Embedded Derivative, Loss on Embedded Derivative of $4.56 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-01.
Discontinued › Notes › Derivative Instruments and Hedging Activities
us-gaap:EmbeddedDerivativeLossOnEmbeddedDerivative · last filed 2018-03-01
- Portola Pharmaceuticals, Inc. embedded derivative, loss on embedded derivative for the quarter ending 2017-12-31 was $3.90M.
- Portola Pharmaceuticals, Inc. embedded derivative, loss on embedded derivative for the quarter ending 2017-09-30 was -$9.00K.
- Portola Pharmaceuticals, Inc. embedded derivative, loss on embedded derivative for fiscal 2017 was $4.56M.
| Period end | Embedded Derivative, Loss on Embedded Derivative 3 month | Embedded Derivative, Loss on Embedded Derivative 6 month | Embedded Derivative, Loss on Embedded Derivative 9 month | Embedded Derivative, Loss on Embedded Derivative 12 month |
|---|---|---|---|---|
| 2017-12-31 | $3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $3.90M derived: sum of 2 quarters · filed 2018-03-01 | $4.56M 10-K · filed 2018-03-01 | |
| 2017-09-30 | -$9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $657.00K 10-Q · filed 2017-11-09 | ||
| 2017-06-30 | $666.00K 10-Q · filed 2017-08-09 |